All-on-4 plus a 14-hour flight: the worst DVT pairing, sold as a package

Let me grant the strongest case for full-arch surgery before I take it apart, because it deserves to be granted. All-on-4 and its full-arch relatives are real, legitimate treatment. For a patient who has lost or is losing a whole arch of teeth, a well-planned, well-executed full-arch rehabilitation can be genuinely transformative, restoring function and dignity that removable dentures often cannot. I am not writing to disparage the procedure. Done properly, for the right patient, by an unhurried surgeon with proper follow-up, it is good dentistry. None of what follows is an argument that full-arch implants are bad.

It is an argument about a pairing. Full-arch surgery is the longest, most immobilizing procedure in routine implant dentistry, and dental tourism routinely bolts it to the longest possible flight home, in the patients least equipped to tolerate either. Two independent risks for venous thromboembolism, surgery and a long-haul flight, are being stacked, in a population enriched for the people who tolerate that stack worst, and the whole thing is sold as a single convenient package. The procedure is sound. The pairing is the problem.

The longest procedure in the chair

Start with what All-on-4 actually involves, because the marketing tends to compress it into a single cheerful phrase about teeth in a day. The procedure replaces a full arch of teeth on, typically, four implants per arch, and it is a substantial surgical undertaking [3]. In a single session it commonly includes extracting remaining teeth, reducing bone to create a flat surgical platform, placing multiple implants at angles, and fitting a provisional fixed bridge, often for both arches in the same visit. That is hours in the chair, not minutes, and it is the most extensive routine procedure in implant dentistry.

Extent and duration of surgery matter for clotting. Surgery induces a transient hypercoagulable state, a period during and after the operation when the body’s clotting system is upregulated as part of the normal wound response, which is why perioperative clot prevention is standard practice across much of surgery [2] [4]. The magnitude of that contribution scales with how long and how extensive the procedure is, and how immobile the patient is around it. I will be careful here: oral and maxillofacial surgery is not high-magnitude on this scale compared with hip or knee replacement, and I will not pretend it is. But full-arch surgery is the high end of dentistry’s range, and the contribution is not zero. The honest question is not whether full-arch surgery alone causes clots. It is what it adds when stacked onto a long flight.

The longest flight home

Now the second risk, established independently and robustly. Long-haul air travel is a recognised risk factor for venous thromboembolism, and the World Health Organization commissioned a dedicated research programme to settle exactly this question [1]. Its findings are consistent and worth stating precisely: the risk of venous thromboembolism rises with flights longer than about four hours, the effect can compound with successive or recent flights, and the absolute risk is concentrated in travellers who already carry additional risk factors [1]. The mechanism is prolonged immobility and venous stasis in the legs, with contributions from cabin conditions, sitting still for hours while blood pools in the lower limbs [1] [2].

Read the WHO additional-risk-factor list and one item leaps out: recent surgery is named as one of the factors that concentrate the travel-related clot risk [1]. The two halves of this argument are not merely independently true. One explicitly names the other. A patient flying long-haul soon after surgery is not combining two unrelated worries; they are placing themselves into the exact high-risk category the WHO programme identified.

Dental tourism, almost by definition, involves a flight, and full-arch tourism involves the longest flights, because the deepest discounts and the most aggressive full-mouth marketing cluster at the far end of long-haul routes. So the longest procedure is routinely paired with the longest flight. A 14-hour flight straight after full-arch surgery is the pairing in its sharpest form.

Stacking is not averaging

Here is the part the package price never reaches. When two risk factors for thrombosis are present together, the combined risk is generally not the simple average of the two, and it is often worse than their sum, because thrombosis risk factors tend to interact [2]. A patient who has just undergone hours of full-arch surgery, the hypercoagulable state, and then sits immobile for fourteen hours in a flight, the stasis state, is combining two pro-thrombotic conditions that push the same direction at the same time.

 THE FULL-ARCH DVT STACK

 Baseline (healthy traveller)              .

 + full-arch surgery                       |||   longest, most extensive
   (hours in chair, extractions,           |||   dental procedure ->
    bone reduction, multiple implants)     |||   hypercoagulable state
                                           |||   (recent surgery is a
                                           |||    NAMED WHO risk factor)

 + long-haul flight 14h                    ||||  independent VTE risk
   (immobility + venous stasis,            ||||  rises beyond ~4h
    well beyond the 4h threshold)          ||||  (WHO travel-VTE work)

 + patient factors                         |||||| older, less mobile,
   (the typical full-arch candidate)       |||||| obesity, prior clot

                                           v
                  risks INTERACT, they do not simply average

 Sold to the patient as: one convenient package, one trip.
 Assessed for combined clot risk:           usually no one.

The diagram is the argument. Every row is independently evidenced. The package price addresses none of them, because the package is built around the dental work and the flight as logistics, and the combined perioperative-thrombosis risk is a question the booking conversation is not structured to ask. I have laid out the general version of this stacking in how DVT risk stacks when dental surgery meets a long-haul flight; this piece is the same logic at its most concentrated, because full-arch is the longest procedure and tourism pairs it with the longest flight.

The cruel alignment

Now the part that moves this from physiology to an editorial position. Read the WHO additional-risk profile again: older age, obesity, reduced mobility, prior clot, recent extensive surgery [1]. Then read who full-arch surgery is sold to. People seeking to replace a whole arch of teeth are, on average, older, because that is when full-arch tooth loss happens [3]. They are more likely to carry the comorbidities that populate the WHO list, more likely to be less mobile, more likely to have a clotting history they have never been asked about.

The alignment runs exactly the wrong way. The procedure that immobilizes the patient longest, paired with the flight that immobilizes them longest, is marketed most aggressively to the population at the highest baseline clot risk. The patient with the most reason to split the journey, to build in recovery before flying, or to have a proper perioperative thrombosis assessment, is the patient offered the most compressed, fly-home-soonest, all-in-one-package itinerary, because that compression is the selling point. This is the dental tourism trust gap at its starkest: the schedule is built to sell, the clot risk the schedule creates is unpriced, and the patient is reassured about the bridge while the thrombosis stack goes unmentioned. The decision the patient should be making, weighing this honestly before booking, is the substance of when it is reasonable to go overseas for dental treatment, and the reason the flight gets set badly in the first place is the subject of why the urge to fly home is about airfare, not biology.

Why no one in the chain owns the risk

A domestic full-arch patient is embedded in a system that, however imperfectly, can coordinate. The surgeon can ask about clotting history, liaise with a general practitioner or haematologist, factor in anticoagulant medication, and is not also selling the patient a flight home. The thrombosis question, when it matters, has somewhere to be asked.

The tourism encounter removes that scaffolding. The intake form is built to assess suitability for the dental work and close the booking, not to perform a perioperative thrombosis assessment, and it frequently does not capture clotting history at all. So the one risk factor the WHO programme explicitly names, recent surgery, gets added to the one travel exposure that programme was built to study, and no one in the chain owns the combined assessment. The clinic owns the dental outcome. The airline owns the flight. The combined perioperative clot risk falls into the gap between them, and the gap lands on the patient, who has not been told it exists. The consequence is not abstract: deep vein thrombosis can present days after the flight, and its dangerous sequel, pulmonary embolism, can be life-threatening and may declare itself once the patient is home on another continent [2]. By then the operating clinic is unreachable, and the patient is left to compute, after the fact, the real cost of a complication, which is the arithmetic I set out in the expected value of a failed implant and its revision.

The questions that change the answer

A patient cannot compute their own combined clot risk, and the failure mode is precisely that no one is asked to. Three concrete questions surface whether the assessment happened.

1. Who assessed my combined thrombosis risk, full-arch surgery plus a flight of this specific length, and what did they conclude? This is a perioperative-medicine question. If the answer names a treatment coordinator rather than a clinician who reviewed your clotting history, age, and mobility against the planned flight, the assessment was not done. The WHO programme’s whole contribution was to identify which travellers carry the concentrated risk [1]; you are entitled to know whether you were screened against that list.

2. Was my flight date set by my risk profile or by my airfare? The dates expose the answer. If the return flight was booked before the surgical plan was finalised, the schedule was an airfare decision and the clot risk was retrofitted into it, not designed around.

3. If a clot presents after I land, who manages it, and at whose cost? Deep vein thrombosis and pulmonary embolism can present days after the flight, by which time the patient is home and the treating clinic is on another continent [2]. If the answer to who manages it is unclear, the risk was never owned by anyone in the chain.

The bottom line

Full-arch surgery is legitimate, often transformative treatment, and I hold that concession without reservation. But it is the longest, most immobilizing procedure in routine implant dentistry [3], and dental tourism routinely pairs it with the longest flight home, in the patients least able to tolerate either. Surgery induces a transient hypercoagulable state. A long-haul flight is an independent thrombosis risk that the World Health Organization commissioned a research programme to characterise, and that programme named recent surgery as one of the factors that concentrate it [1] [2]. The two stack, they interact rather than average, and they are sold most aggressively, in their most compressed single-trip form, to the older and less mobile patients who carry the most baseline risk. The procedure is sound. The pairing is the danger, and the package price never names it. I cannot give you a precise combined-risk figure, because the honest literature does not provide one for oral surgery specifically, and I will not invent it. But I can tell you the direction is not in doubt and the assessment is almost never done. The least a patient at this end of the risk curve can demand is to know who, if anyone, looked at the stack before booking the flight into it. See also our methodology and standing disclosures.